查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球胰島素給藥設備市場研究報告 - 2023 年至 2030 年的行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1314756

全球胰島素給藥設備市場研究報告 - 2023 年至 2030 年的行業分析、規模、佔有率、成長、趨勢和預測

Global Insulin Delivery Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

據預測，胰島素給藥設備市場的全球需求將從2022 年的201.2 億美元增至2030 年的近447.3 億美元，2023-2030 年的複合年成長率為10.5%。在數量方面，2022 年的市場規模為XX 千台，預計到2030 年將達到XX 千台，2023-2030 年的複合年成長率為XX%。

胰島素給藥裝置用於為確診為糖尿病的患者注射胰島素。胰島素是一種激素，由胰腺分泌，可調節血糖水準。糖尿病患者的身體要么不能產生足夠的胰島素（1 型糖尿病），要么不能有效利用所產生的胰島素（2 型糖尿病）。胰島素治療對控製糖尿病和維持最佳血糖控制至關重要。

市場動態：

隨著越來越多的人被診斷出患有糖尿病並需要接受胰島素治療，全球糖尿病患病率的不斷上升成為主要驅動因素。創新的胰島素給藥設備具有精確給藥、更高的可用性、連接性和數據追踪功能等特點，提高了便利性和治療效果。由於胰島素泵設計的改進、使用的簡便性和更好的報銷政策，胰島素泵療法的採用率正在上升。患者的舒適度和便利性正變得越來越重要，這促使人們開發出能最大限度減少疼痛、提供隱蔽性並簡化胰島素給藥過程的設備。人們對糖尿病管理、胰島素治療以及胰島素給藥設備的益處的認知和教育不斷提高，促進了這些設備被更廣泛地接受和採用。政府的支持政策和報銷制度促進了胰島素治療的普及，從而進一步刺激了市場的成長。人口老齡化，加上久坐不動的生活方式和不健康的飲食習慣等生活方式的改變，導致糖尿病發病率上升。人口結構的變化和生活方式的改變促使對胰島素給藥裝置的需求不斷增加。

報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構，評估全球競爭吸引力。此外，這些工具還對全球胰島素給藥裝置市場的各個細分市場進行了全面評估。胰島素給藥裝置行業的成長和趨勢為本研究提供了一種全面的方法。

區域分析：

本部分涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲地區胰島素給藥裝置市場的當前和未來需求。此外，報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

研究報告還涵蓋了市場中主要企業的綜合概況以及全球競爭格局的深入分析。胰島素給藥設備市場的主要參與者包括Becton, Dickinson and Company（美國）、Novo Nordisk A/S（丹麥）、Ypsomed Holding AG（瑞士）、Medtronic plo（愛爾蘭）、Animas Corporation（美國）、Tandem Diabetes Care, Inc.(印度）。禮來公司（美國）和Insulet 公司（美國）。本部分對競爭格局進行了整體分析，包括各種戰略發展，如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品上市及其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可根據您的需求提供客製化報告。

目 錄

第1 章：前言

  • 報告說明
    • 目標
    • 目標受眾
    • 獨特銷售主張(USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場調研過程
    • 市場調研方法

第2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第3 章：胰島素給藥裝置- 行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場阻礙因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格趨勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章：全球胰島素給藥裝置市場分析：按類型分類

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 筆（可重複使用筆、 拋棄式筆）
  • 泵（外置/繫帶泵、貼片泵）
  • 筆針（標準筆針、Salety 筆針）
  • 注射器
  • 其他設備

第6 章：全球胰島素給藥裝置市場分析：按最終用戶分類

  • 終端用戶概述
  • 歷史和預測數據
  • 按最終用戶分析
  • 患者/家庭護理
  • 醫院和診所

第7 章：全球胰島素給藥裝置市場分析：按地區分類

  • 地區展望
  • 簡介
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美地區銷售分析
    • 北美地區各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲分部銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲各地區銷售分析
    • 中東和非洲各國銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第8章: 胰島素給藥裝置企業的競爭格局

  • 胰島素給藥裝置市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品上市
  • 其他發展

第九章: 公司概況

  • 頂級公司市場佔有率分析
  • 市場集中率
  • Becton
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Dickinson and Company (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Novo Nordisk A/S (Denmark)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Ypsomed Holding AG (Switzerland)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Medtronic plo (Ireland)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Animas Corporation (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Tandem Diabetes Care Inc. (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Sanofi (France)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Biocon Ltd. (India).
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Eli Lilly and Company (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Insulet Corporation (US)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

注：在公司概況中，財務細節和近期發展視情況而定，私營公司可能不包括在內。

Product Code: VMR112111556

The global demand for Insulin Delivery Devices Market is presumed to reach the market size of nearly USD 44.73 BN by 2030 from USD 20.12 BN in 2022 with a CAGR of 10.5% under the study period of 2023 - 2030. Regarding volume, the market was calculated XX Thousand Units in 2022 and forecast to touch XX Thousand Units by 2030 with a CAGR of XX% during 2023-2030.

Insulin delivery devices are employed for the purpose of administering insulin to individuals diagnosed with diabetes. Insulin, a hormone, is produced by the pancreas that regulates blood sugar levels. In people with diabetes, the body either does not produce enough insulin (Type 1 diabetes) or does not effectively use the insulin produced (Type 2 diabetes). Insulin therapy is essential for managing diabetes and maintaining optimal blood glucose control.

MARKET DYNAMICS:

The increasing prevalence of diabetes worldwide is a key driver, as more individuals are diagnosed with diabetes and require insulin therapy. Innovative insulin delivery devices with features like accurate dosing, improved usability, connectivity, and data tracking capabilities have enhanced convenience and treatment outcomes. The adoption of insulin pump therapy is on the rise, thanks to improved pump designs, ease of use, and better reimbursement policies. Patient comfort and convenience are becoming increasingly important, leading to the development of devices that minimize pain, offer discreetness, and simplify insulin administration processes. Awareness and education about diabetes management, insulin therapy, and the benefits of insulin delivery devices have increased, contributing to their wider acceptance and adoption. Supportive government policies and reimbursement systems further stimulate market growth by promoting access to insulin therapy. The ageing population, coupled with lifestyle changes such as sedentary lifestyles and unhealthy eating habits, has resulted in a higher prevalence of diabetes. This demographic shift and lifestyle factors contribute to the increasing demand for insulin delivery devices.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of insulin delivery devices. The growth and trends of Insulin Delivery Devices Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the insulin delivery devices market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Pers (Reusable Pens, Disposable Pens)
  • Pumps (External/ Tethered Pumps, Patch Pumps)
  • Pen Needles (Standard Pen Needles, Salety Pen Needles)
  • Syringes
  • Other Devices

By End User

  • Patients/Homecare
  • Hospitals & Clinics

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Insulin Delivery Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the insulin delivery devices market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plo (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India). Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . INSULIN DELIVERY DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By End User
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL INSULIN DELIVERY DEVICES MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Pers (Reusable Pens, Disposable Pens) Historic and Forecast Sales by Regions
  • 5.5 Pumps (External/ Tethered Pumps, Patch Pumps) Historic and Forecast Sales by Regions
  • 5.6 Pen Needles (Standard Pen Needles, Salety Pen Needles) Historic and Forecast Sales by Regions
  • 5.7 Syringes Historic and Forecast Sales by Regions
  • 5.8 Other Devices Historic and Forecast Sales by Regions

6 . GLOBAL INSULIN DELIVERY DEVICES MARKET ANALYSIS BY END USER

  • 6.1 Overview by End User
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End User
  • 6.4 Patients/Homecare Historic and Forecast Sales by Regions
  • 6.5 Hospitals & Clinics Historic and Forecast Sales by Regions

7 . GLOBAL INSULIN DELIVERY DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE INSULIN DELIVERY DEVICES COMPANIES

  • 8.1. Insulin Delivery Devices Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF INSULIN DELIVERY DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Becton
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Dickinson and Company (U.S.)
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Novo Nordisk A/S (Denmark)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Ypsomed Holding AG (Switzerland)
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Medtronic plo (Ireland)
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Animas Corporation (U.S.)
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Tandem Diabetes Care Inc. (U.S.)
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Sanofi (France)
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Biocon Ltd. (India).
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Eli Lilly and Company (U.S.)
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Insulet Corporation (U.S.)
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (Thousand Units and USD MN)
  • Pers (Reusable Pens, Disposable Pens) Market Sales by Geography (Thousand Units and USD MN)
  • Pumps (External/ Tethered Pumps, Patch Pumps) Market Sales by Geography (Thousand Units and USD MN)
  • Pen Needles (Standard Pen Needles, Salety Pen Needles) Market Sales by Geography (Thousand Units and USD MN)
  • Syringes Market Sales by Geography (Thousand Units and USD MN)
  • Other Devices Market Sales by Geography (Thousand Units and USD MN)
  • Analysis Market by End User (Thousand Units and USD MN)
  • Patients/Homecare Market Sales by Geography (Thousand Units and USD MN)
  • Hospitals & Clinics Market Sales by Geography (Thousand Units and USD MN)
  • Global Insulin Delivery Devices Market Sales by Geography (Thousand Units and USD MN)
  • North America Market Analysis (Thousand Units and USD MN)
  • United State Market Analysis (Thousand Units and USD MN)
  • Canada Market Analysis (Thousand Units and USD MN)
  • Mexico Market Analysis (Thousand Units and USD MN)
  • Europe Market Analysis (Thousand Units and USD MN)
  • Europe Market Estimate by Country (Thousand Units and USD MN)
  • United Kingdom Market Analysis (Thousand Units and USD MN)
  • France Market Analysis (Thousand Units and USD MN)
  • Germany Market Analysis (Thousand Units and USD MN)
  • Italy Market Analysis (Thousand Units and USD MN)
  • Russia Market Analysis (Thousand Units and USD MN)
  • Spain Market Analysis (Thousand Units and USD MN)
  • Rest of Europe Market Analysis (Thousand Units and USD MN)
  • Asia Pacific Market Analysis (Thousand Units and USD MN)
  • China Market Analysis (Thousand Units and USD MN)
  • Japan Market Analysis (Thousand Units and USD MN)
  • India Market Analysis (Thousand Units and USD MN)
  • South Korea Market Analysis (Thousand Units and USD MN)
  • Australia Market Analysis (Thousand Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Thousand Units and USD MN)
  • Latin America Market Analysis (Thousand Units and USD MN)
  • Brazil Market Analysis (Thousand Units and USD MN)
  • Argentina Market Analysis (Thousand Units and USD MN)
  • Peru Market Analysis (Thousand Units and USD MN)
  • Chile Market Analysis (Thousand Units and USD MN)
  • Rest of Latin America Market Analysis (Thousand Units and USD MN)
  • Middle East & Africa Market Analysis (Thousand Units and USD MN)
  • Saudi Arabia Market Analysis (Thousand Units and USD MN)
  • UAE Market Analysis (Thousand Units and USD MN)
  • Israel Market Analysis (Thousand Units and USD MN)
  • South Africa Market Analysis (Thousand Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Thousand Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Insulin Delivery Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Insulin Delivery Devices Market Size, by Region (Thousand Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (Thousand Units and USD MN)
  • Pers (Reusable Pens, Disposable Pens) Market Sales by Geography (Thousand Units and USD MN)
  • Pumps (External/ Tethered Pumps, Patch Pumps) Market Sales by Geography (Thousand Units and USD MN)
  • Pen Needles (Standard Pen Needles, Salety Pen Needles) Market Sales by Geography (Thousand Units and USD MN)
  • Syringes Market Sales by Geography (Thousand Units and USD MN)
  • Other Devices Market Sales by Geography (Thousand Units and USD MN)
  • Global Market Analysis by End User (Thousand Units and USD MN)
  • Patients/Homecare Market Sales by Geography (Thousand Units and USD MN)
  • Hospitals & Clinics Market Sales by Geography (Thousand Units and USD MN)
  • Global Market Sales (Thousand Units and USD MN)
  • North America Market Sales (Thousand Units and USD MN)
  • Europe Market Sales (Thousand Units and USD MN)
  • Asia Pacific Market Sales (Thousand Units and USD MN)
  • Latin America Market Sales (Thousand Units and USD MN)
  • Middle East & Africa Market Sales (Thousand Units and USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.